BiomeSense is a developing novel technologies to enable continuous, at-home monitoring of the human microbiome.
BiomeSense has raised $6.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2023.
BiomeSense's investors include National Science Foundation, SOSV, IndieBio, Overton Venture Capital, Bluestein Ventures.
BiomeSense is headquartered in Chicago, United States.
BiomeSense is a developing novel technologies to enable continuous, at-home monitoring of the human microbiome.
BiomeSense is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BiomeSense — Funding & Investors." VCBacked, December 19, 2023, https://www.vcbacked.co/company/biomesense. Accessed July 19, 2026.
VCBacked. (2023). BiomeSense — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/biomesense
{{cite web |title=BiomeSense — Funding & Investors |url=https://www.vcbacked.co/company/biomesense |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated